{"title":"硝酸依柏康唑微乳剂的局部给药:配方、设计和评估","authors":"Nidhi Shah, Khushbu Patel, Indrajeet Singhvi","doi":"10.25004/ijpsdr.2023.150412","DOIUrl":null,"url":null,"abstract":"The objective of the present research work was to develop a microemulsion for the transdermal delivery of eberconazole nitrate (EBZ). Initially, oil, surfactant and co-surfactant were selected based on their solubility and emulsification study. A pseudoternary phase diagram was constructed to optimize the surfactant-co surfactant (Smix) ratio. Eberconazole nitrate (EBZ) loaded microemulsion was optimized using central composite design (CCD) with amount of Capmul MCM (X1), tween 80 (X2) and transcutol (X3) as independent variables along with the cumulative amount of drug release (Q24) (Y1), flux (Jss) (Y2) and lag time (tL) (Y3) as dependent variables. Drug release study of all the design batches showed successfully increased permeation of drug which might be due to the compositional characteristics of ME. The globule size of the optimized batch of EBZ loaded ME (153.6 nm) confirms the micrometer size of the formulation. Zeta potential and polydispersity index (PDI) of the optimized batch was found to be -30.5 mV and 0.253, respectively, proving stability and uniform distribution of dispersed systems. The optimized batch of MEs has a pH value of 6.96 ± 0.21, indicating no chance of skin irritation. Further morphological and structural examination of the optimized batch of EBZ loaded ME was done by transmission electron microscope (TEM) and images illustrated the spherical micelles with size range of 100 to 200 nm which evidently may support the high absorption and results into the enhancement of drug permeation which may increase the therapeutic effect, decrease the dose frequency and improving the patience compliance for topical drug delivery.","PeriodicalId":14278,"journal":{"name":"International Journal of Pharmaceutical Sciences and Drug Research","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Topical Delivery of Eberconazole Nitrate Loaded Microemulsion: Formulation, Design and Evaluation\",\"authors\":\"Nidhi Shah, Khushbu Patel, Indrajeet Singhvi\",\"doi\":\"10.25004/ijpsdr.2023.150412\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The objective of the present research work was to develop a microemulsion for the transdermal delivery of eberconazole nitrate (EBZ). Initially, oil, surfactant and co-surfactant were selected based on their solubility and emulsification study. A pseudoternary phase diagram was constructed to optimize the surfactant-co surfactant (Smix) ratio. Eberconazole nitrate (EBZ) loaded microemulsion was optimized using central composite design (CCD) with amount of Capmul MCM (X1), tween 80 (X2) and transcutol (X3) as independent variables along with the cumulative amount of drug release (Q24) (Y1), flux (Jss) (Y2) and lag time (tL) (Y3) as dependent variables. Drug release study of all the design batches showed successfully increased permeation of drug which might be due to the compositional characteristics of ME. The globule size of the optimized batch of EBZ loaded ME (153.6 nm) confirms the micrometer size of the formulation. Zeta potential and polydispersity index (PDI) of the optimized batch was found to be -30.5 mV and 0.253, respectively, proving stability and uniform distribution of dispersed systems. The optimized batch of MEs has a pH value of 6.96 ± 0.21, indicating no chance of skin irritation. Further morphological and structural examination of the optimized batch of EBZ loaded ME was done by transmission electron microscope (TEM) and images illustrated the spherical micelles with size range of 100 to 200 nm which evidently may support the high absorption and results into the enhancement of drug permeation which may increase the therapeutic effect, decrease the dose frequency and improving the patience compliance for topical drug delivery.\",\"PeriodicalId\":14278,\"journal\":{\"name\":\"International Journal of Pharmaceutical Sciences and Drug Research\",\"volume\":\"38 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutical Sciences and Drug Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25004/ijpsdr.2023.150412\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutical Sciences and Drug Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25004/ijpsdr.2023.150412","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
本研究工作的目的是开发一种用于硝酸依康唑(EBZ)透皮给药的微乳剂。最初,根据油、表面活性剂和辅助表面活性剂的溶解性和乳化研究,对它们进行了选择。为了优化表面活性剂与辅助表面活性剂(Smix)的比例,构建了一个假三元相图。以 Capmul MCM(X1)、吐温 80(X2)和 transcutol(X3)的用量为自变量,以药物释放累积量(Q24)(Y1)、通量(Jss)(Y2)和滞后时间(tL)(Y3)为因变量,采用中心复合设计(CCD)对负载硝酸依康唑(EBZ)的微乳剂进行了优化。所有设计批次的药物释放研究均显示药物渗透性成功增加,这可能与 ME 的成分特性有关。优化批次的 EBZ 负载 ME 的球形尺寸(153.6 nm)证实了制剂的微米尺寸。优化批次的 Zeta 电位和多分散指数(PDI)分别为 -30.5 mV 和 0.253,证明了分散体系的稳定性和均匀分布。优化批次 ME 的 pH 值为 6.96 ± 0.21,表明不会对皮肤产生刺激。透射电子显微镜(TEM)对优化批次的 EBZ 负载 ME 进行了进一步的形态和结构检查,图像显示其为球形胶束,尺寸范围为 100 至 200 nm。
Topical Delivery of Eberconazole Nitrate Loaded Microemulsion: Formulation, Design and Evaluation
The objective of the present research work was to develop a microemulsion for the transdermal delivery of eberconazole nitrate (EBZ). Initially, oil, surfactant and co-surfactant were selected based on their solubility and emulsification study. A pseudoternary phase diagram was constructed to optimize the surfactant-co surfactant (Smix) ratio. Eberconazole nitrate (EBZ) loaded microemulsion was optimized using central composite design (CCD) with amount of Capmul MCM (X1), tween 80 (X2) and transcutol (X3) as independent variables along with the cumulative amount of drug release (Q24) (Y1), flux (Jss) (Y2) and lag time (tL) (Y3) as dependent variables. Drug release study of all the design batches showed successfully increased permeation of drug which might be due to the compositional characteristics of ME. The globule size of the optimized batch of EBZ loaded ME (153.6 nm) confirms the micrometer size of the formulation. Zeta potential and polydispersity index (PDI) of the optimized batch was found to be -30.5 mV and 0.253, respectively, proving stability and uniform distribution of dispersed systems. The optimized batch of MEs has a pH value of 6.96 ± 0.21, indicating no chance of skin irritation. Further morphological and structural examination of the optimized batch of EBZ loaded ME was done by transmission electron microscope (TEM) and images illustrated the spherical micelles with size range of 100 to 200 nm which evidently may support the high absorption and results into the enhancement of drug permeation which may increase the therapeutic effect, decrease the dose frequency and improving the patience compliance for topical drug delivery.